DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration in Next Generation Probiotics

COPENHAGEN, Denmark, Sept. 21, 2020 /PRNewswire-PRWeb/ -- The DuPont Human Microbiome Venture today announced a research partnership with The Procter & Gamble Company (P&G), focusing on the discovery and development of innovative next generation probiotics (NGPs) for human health.

Over the past years, both P&G and DuPont have conducted extensive research on human commensals to help address metabolic health issues in humans. In order to accelerate the development and commercialization of NGPs, both companies are joining forces to develop NGPs, initially to be used in dietary supplements.

There is an increasing number of studies that have shown that diet and poor lifestyle choices negatively affect the gut microbiota which can result in chronic low-grade inflammation which is closely associated with the onset and prevalence of metabolic health related conditions¹. On the contrary, increasing levels of certain anaerobic bacteria in the gut has been shown to increase insulin sensitivity and thus helps to maintain healthy blood sugar levels.²

"It's an exciting opportunity to partner with P&G to jointly develop the next generation of microbe-based products. The combination of DuPont's and P&G's unique set of capabilities will allow us to accelerate innovation in the field of metabolic health and help millions of consumers affected by metabolic health issues," said Sebastien Guery, Human Microbiome Venture leader, DuPont Nutrition & Biosciences.

"As a company focused on innovation, P&G is excited to come together with our valued partners at DuPont. Many consumers trust Align, the #1 doctor and gastroenterologist recommended probiotic brand³, to promote and support a healthy digestive system⁴. This strategic partnership will help us further advance our probiotic innovation via a next generation solution that will prove beneficial to the health and well-being of consumers around the world" said Paul Gama, president, P&G Personal Health Care.

¹Tilg H et al. The intestinal microbiota fuelling metabolic inflammation. Nature Reviews Immunology 2020; 20:40-54.
² Vrieze A et al. Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome. Gastroenterology 2012; 143:913–916.
³ Among Gastroenterologists who recommended a brand of probiotic in a ProVoice 2008-2019 survey. Among Doctors who recommended a brand of probiotic in ProVoice 2013-2019 surveys.
⁴ These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About P&G
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.

About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com/.

# # #

09/21/2020
DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

SOURCE DuPont